A Prescription For Better Stroke Care

A Prescription For Better Stroke Care

Geoff Koehler, St. Michael's Hospital Stroke patients are 70 percent more likely to continue taking their stroke prevention medications one year later if they have a prescription in hand when discharged – according to researchers at St....

Latest stroke Stories

2014-08-28 12:29:37

BOSTON, Aug. 28, 2014 /PRNewswire/ -- The North American Thrombosis Forum (NATF), a non-profit organization dedicated to increasing public awareness of thrombosis and related cardiovascular diseases, is thrilled to welcome 7 renowned experts in cardiovascular medicine to speak at their Fall educational program, the 8(th) Annual Thrombosis Summit, on Saturday, September 20. The Thrombosis Summit will take place at the beautiful Fairmont Copley Plaza Hotel located in Copley Square in...

2014-08-27 23:14:37

The second annual Brain Aneurysm Awareness Run (BAAR) will take place in Wayne, PA on Saturday, September 6, 2014. All proceeds benefit the world renowned Brain Aneurysm Foundation. Hanover, MA (PRWEB) August 27, 2014 As part of the ongoing effort to increase awareness of brain aneurysms, organizers of last year’s very successful Brain Aneurysm Awareness Run (BAAR) have scheduled their 2nd annual event to take place on Saturday, September 6, 2014 in Wayne, Pennsylvania. Founded in 2013...

2014-08-27 23:12:45

A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C. (PRWEB) August 27, 2014 A recently published study by the Journal of Neurosurgery discusses the importance of time in correcting coagulopathy to prevent permanent injury or death. The study focuses on a variety of anticoagulants and examines medical conditions alleged to be caused by these drugs. According to the research, although...

2014-08-25 08:27:37

-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014 Hot Line Session RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that results from the Phase 3b exploratory X-VeRT study, investigating the oral Factor Xa inhibitor XARELTO(®) (rivaroxaban) in patients with non-valvular atrial...

2014-08-25 08:27:31

Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug. 25, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from nine company-sponsored Pradaxa® (dabigatran etexilate mesylate) studies will be presented at the European Society of Cardiology (ESC) Congress 2014, August 30 to September 3 in Barcelona, Spain. The abstracts will feature data about the use...

2014-08-20 23:07:40

Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville, MD (PRWEB) August 20, 2014 The National Blood Clot Alliance (NBCA), a nonprofit advocacy organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots, announces the appointment of Randy Fenninger, JD, as its new Chief Executive Officer (CEO). Fenninger, who...

heart thinkstock 452128839
2014-08-20 03:30:48

American Heart Association Rapid Access Journal Report U.S. hospitalizations and deaths from heart disease and stroke dropped significantly in the last decade, according to new research in the American Heart Association journal Circulation. “Interestingly, these improvements happened in a period when there were no real ‘miracle’ clinical advancements,” said Harlan Krumholz, M.D., S.M., lead author of the “most comprehensive report card to-date” on America’s progress in...

2014-08-13 23:02:06

The Firm is evaluating Xarelto lawsuits on behalf of individuals who allegedly suffered intracranial hemorrhage, spinal and epidural hematoma, gastrointestinal hemorrhage, adrenal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death due to their use of the blood thinner. New York, NY (PRWEB) August 13, 2014 Xarelto lawsuits (http://www.injurybeacon.com/xarelto/lawsuit/) filed on behalf of individuals who were allegedly harmed by the blood thinner continue to mount in U.S....

2014-08-12 23:12:39

New York Drug Liability Lawyer discusses the dangers of the anticoagulant drug Xarelto and the potential risks involved when taking Xarelto. (PRWEB) August 12, 2014 Xarelto is an oral anticoagulant drug used to prevent blood clots, and also lowers the risk of stroke in patients who have atrial fibrillation. Xarelto’s official website 06/17/2014 states, “People with atrial fibrillation (an irregular heart beat) are at an increased risk of forming a blood clot in the heart, which can...

2014-08-12 23:10:53

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) August 12, 2014 The drug safety advocates at DrugNews.net have added a new resource section for patients who have taken the anticoagulant drug Xarelto. Recent reports show internal bleeding complaints for the drug have risen past similar medications*. DrugNews is a free resource providing the latest product recalls, safety...

Latest stroke Reference Libraries

2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »
Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'